Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 1 of 1612345...10...Last »

FDA expects IV fluid shortage to improve in coming weeks, months

The U.S. FDA expects a shortage of intravenous saline fluids for hospitals due to damage to key manufacturing facilities in Puerto Rico to improve over the coming weeks and months.

Read More »

Eli Lilly on the Hunt for Cancer Deals to Beef Up Pipeline

In terms of acquisitions, the company is looking to expand its immunology pipeline as well as oncology.

Read More »

Human antibodies made in cows could be developed to treat MERS

Human antibodies made in genetically engineered cows have proved safe in an early-stage clinical trial.

Read More »

FDA expands use of Amgen’s blockbuster drug

Amgen Inc. said the U.S. FDA approved its drug Xgeva to prevent fractures in patients with multiple myeloma.

Read More »

Philippines fines Sanofi, suspends clearance for Dengvaxia

The Philippines suspended clearance for Sanofi’s dengue vaccine Dengvaxia and fined the French drugmaker.

Read More »

New drug approvals hit 21-year high in 2017

U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light — more than double the previous year — while the figure also rose in the EU.

Read More »

Top 20 Life Science Startups to Watch in 2018

BioSpace present its NextGen Bio “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.

Read More »

China: U.S. should do more to cut opioid demand

The United States should take action to reduce demand for the drugs fueling its deadly opioid crisis, a top Chinese drug control official said.

Read More »

Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion

Mallinckrodt plc will acquire Sucampo Pharmaceuticals Inc., including its commercial and development assets.

Read More »

California court says Novartis can be sued over generic drug injuries

California’s top court opened the door for consumers to sue Novartis AG and other makers of brand-name pharmaceutical products over injuries blamed on generic versions of the drugs manufactured by other companies.

Read More »

Roche scores cancer drug approvals in Europe, U.S.

Swiss drugmaker Roche won approvals for two cancer drugs in Europe and the United States, shoring up its position in new medicines as it braces for falling sales of older products.

Read More »

France fines J&J 25 million euros over painkiller patch

France’s competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.6 million) after it ruled the company had deliberately slowed market access to generic copies of its painkiller Durogesic.

Read More »

Chocolate makers innovate to entice health-conscious consumers

The world’s largest chocolate makers are looking for ways to keep increasingly health-conscious consumers coming back for more.

Read More »

Germany’s Merck in fresh bid to enter U.S. MS pill market

Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulatory concerns about side effects having frustrated the German company’s ambitions almost seven years ago.

Read More »

Daichi Sankyo Abandons Deal With Nektar Therapeutics After Drug Tanks in Europe

Daiichi Sankyo Europe GmbH informed Nektar Therapeutics that it was terminating a collaboration and licensing deal, which becomes effective Feb. 4, 2018. All rights and licenses that Daiichi acquired in the deal will revert to Nektar.

Read More »

Half of world’s people can’t get basic health services: WHO

At least half the world’s population is unable to access essential health services and many others are forced into extreme poverty by having to pay for healthcare they cannot afford, the World Health Organization said.

Read More »

Sanofi pins hopes on new drugs after setbacks

Sanofi management expressed confidence that the company’s pipeline of new products will support long-term growth.

Read More »

PhRMA sues to stop California drug price law

The trade group representing U.S. drugmakers filed a lawsuit to stop California from implementing a law aimed at reining in prescription drug prices.

Read More »

Philippines to seek refund of $59 million from Sanofi amid vaccine risk

The Philippines will seek the return of 3 billion pesos ($59 million) it paid French drugmaker Sanofi for a dengue vaccine used to immunize hundreds of thousands of children that Sanofi has said could worsen the disease in some cases.

Read More »

Australian watchdog takes GlaxoSmithKline, Novartis units to court

The Australian Competition and Consumer Commission said the ACCC is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

Read More »

Page 1 of 1612345...10...Last »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

December 2017 Focus: Ad Agency Roundtable and more!

Subscribe

Ad Right Bottom

Main Navigation